BusinessKoreaKorea-based biotechnology company Medipost announced on December 16 that it signed a license agreement with Indian pharmaceutical company Alkem Laboratories Ltd for its stem cell-based cartilage repair drug Cartistem. This is the first time for local read more
http://blog.zandcell.com/korean-stem-cell-drugs-push-into-global-market-businesskorea/?utm_source=rss&utm_medium=rss&utm_campaign=korean-stem-cell-drugs-push-into-global-market-businesskorea
Inga kommentarer:
Skicka en kommentar